|Project name ||100,000 Genomes Project - there are 5 reports for this project: 2015, 2016, 2017, 2018, 2019 |
|Google search ||Google search on project name (opens in new window) |
|Contracts ||Contracts search (opens in new window) - under development |
|Organisation ||DHSC (D12) - see all reports for this organisation |
|Report year ||2018 (data is from September 2017) |
|Category ||Transformation - see all reports for this category |
|Description: ||The primary aim of this programme is to deliver the then Prime Minister , David Cameron's, commitment to sequence 100,000 whole human genome samples by December 2018. The Project has four specific aims: to bring benefit to patients and create a genomic medicine service for the NHS; to enable new scientific discovery and medical insights; to create an ethical and transparent programme based on consent; to kick start the development of a UK genomics industry. |
|DCA (RAG) || Amber |
|DCA text: ||The improved RAG rating reflects the good progress made and clear focus on preparation for transitioning the project into a Genomics Medicine Service. SRO and Programme Director continue to proactively challenge delivery partners (e.g. Genomics England on informatics and NHS England on GMCs providing samples) at the Project Delivery Board. Ministers, No 10 and the IPA understand current status, delivery challenges relating to this world-leading project. |
|Start date ||2013-04-10 |
|End date ||2018-12-31 |
|Schedule text ||To fulfil the vision of the Project, we are always working at the edge of known science. We have made good progress, but as with all scientific research, it takes time to get it right. This is why Genomics England, the Department of Health and NHS England have all agreed that the project will be extended from 2017 until the end of 2018.
Genomics England and NHS England report that recruitment of the rare disease element of the project is going well. Delivery of the cancer element of the project remains challenging but is improving.
Cancer Accelerator sites and a fast turnaround of cancer reports and additional resources should improve recruitment. The option is being explored as a contingency to open the sequencing to other research cohorts if necessary for cancer recruitment to ensure the target is met. |
|Baseline ||£77.80m |
|Forecast ||£77.80m |
|Variance ||0.00% |
|Variance text: ||Budget variance less than 5% |
|Whole Life Cost ||£392.90m |
|WLCost text: ||Budgeted Whole Life Costs is £392.9m for Genomics England and Health Education England (HEE).
Increase in budget for 17/18 was due to an expected increase in samples being collected by GMCs and the HEE spend which is more accurately shown as addition to the baseline whole life costs. |
|Notes1: || 100000 Genomes Project |
|Notes2: || |
|Sourcefile ||IPA_2018.csv |
Acknowledgement: GMPP data has been re-used under the Open Government Licence.